Clinical trial · Interventional
the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.
Evaluation of the Efficacy & Safety of Topical Ivermectin Alone or in Combination With Microneedling as Novel Therapeutic Options for Cutaneous Non-genital Warts Versus Topical Salicylic Acid ؛ Randomized Controlled Clinical Trial.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To compare between the efficacy and safety of topical ivermectin alone, microneedling with topical ivermectin and topical salicylic acid in treatment of cutaneous warts. topical ivermectin 1% will be applied on warts whole night clinical assessment will be done every 2 weeks Microneedling will be performed on the lesion using a microneedling pen type device with a 1-cm tip diameter at a 2-mm depth setting for 2-3 minutes until pinpoint bleebing occurs 1 mL of topical ivermectin 1% will be applied on to the wart tissue. Sessions: Sessions will be performed every 2 weeks until complete cure or for maximum 6 sessions (total 3 month)
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Warts | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ivermectin | Drug | — | UNRESOLVED |
| microneedling | Device | — | UNRESOLVED |
| Salicylic Acid | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- topical ivermectin
- interventionNames
- Drug: Ivermectin
- type
- EXPERIMENTAL
- label
- microneedling
- description
- patients with cutaneous warts will be treated with microneedling.
- interventionNames
- Device: microneedling
- type
- EXPERIMENTAL
- label
- microneedling with ivermectin
- description
- patients with cutaneous warts will be treated with topical ivermectin with microneedling.
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 11 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * patients with cutaneous non genital warts aged 11:80 y. * No concurrent systemic or topical treatment of warts Exclusion Criteria: * Genital warts. * Pregnancy and lactation. * History of any bleeding, clotting disorder or using anticoagulants * Chronic systemic diseases such as chronic renal failure, hepaticinsufficiency, and cardiovascular disorders. * patients who received any treatment for warts in the last month before the study. * Patients with history of neuropathy or peripheral ischemia. * Patients with signs of inflammation or infection. * Patients with history of a serious systemic or anaphylactic reaction or allergy to ivermectin.
References
Publications (1)
- BACKGROUNDMehta N. Case study of oral ivermectin in patients with cutaneous warts. J Cardiovasc Dis Res. 2024;15(12):6438-46